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Transketolase (TK, EC.2.2.1.1) is a thiamine-dependent enzyme
which is widely used for assessing thiamine deficiency. The TK
activity in erythrocytes is usually decreased during thiamine
deficiency and this activity can be enhanced in vitro by the
addition of thiamine pyrophosphate (TPP). The relative
increase in enzyme activity, expressed as a percentage, is called
the TPP effect.
The TK kinetic method proposed by Smeets et al. [1] is
relatively simple and specific and is based on the measurement of
NADH decrease. Minor modifications ofthis method have been
proposed [2 and 3] but the method remains tedious if several
specimens are assayed. To further simplify the assay, we have
modified the method of Smeets et al. for a discrete enzyme
analyser, the Gilford System 5 (Gilford Instrument Laboratories
Inc., Oberlin, Ohio, USA) to give a very simple, economical and
convenient method.
Method
Reagents
These are essentially similar to those of Smeets et al., but the
preparation of reagents modified to improve their storage is
outlined.
(1) Tris buffer, 0’ mol/1, pH 7"8 at room temperature [RT].
Dissolve 10.64 g Trizma HC1 (Sigma) and 3.94 g Trizma
base (Sigma) in 1.0 litres of water. Store at RT.
(2) Thiamine pyrophosphate, 0.01mol/1 in tris buffer.
Dissolve 46.1mg TPP (Sigma) in 10ml buffer. Store
1.0 ml portions at 20C.
(3) Ribose-5-phosphate, 37.5 mmol/l in tris buffer. Dissolve
g sodium ribose-5-phosphate (Sigma) in 91 ml buffer.
Store at -20C in 5 or 10ml portions (unused portions
can be refrozen and reused).
(4) NADH, 0.01mol/1 in tris buffer. Dissolve 7.46mg
NADH.Na2 (Sigma) in 1.0ml buffer. Prepare fresh the
approximate amount required.
(5) Glycerol-3-phosphate dehydrogenase/triosephosphate
isomerase(GDH/TIM; 2 mg/ml) in ammonium sulphate
solution (Boehringer). Store at 4C.
Sample preparation
Blood is collected in a heparinized tube and centrifuged as soon
as possible. The plasma and buffy coat are removed and the
erythrocytes washed in cold physiological saline and again
centrifuged. The packed erythrocytes are haemolysed by mixing
with an equal volume of sterox solution 5ml/1 (Sterox SE,
Harleco Company, Philadelphia, Pennsylvania 19143, USA),
and stored at -20C.
Just prior to the assay, the haemoglobin concentration is
determined by the cyanmethaemoglobin method. This con-
centration is then adjusted to 30 g/1 with saline and centrifuged
to obtain a haemolysate free of stroma.
Gilford System 5
This is a discrete analyser which consists ofa spectrophotometer
with a flow-through thermocuvette, computer/printer, auto-
matic dispenser and specimen transport. There are several
operating modes including kinetic pre-programmed and general
modes, making the analyser versatile and simple to use.
In the kinetic mode the specimen is placed into cups in the
transport carousel. The reagent is placed into the automatic
dispenser and the computer is programmed to the requirements
ofthe assay. When in operation, the required volume ofreagent
is dispensed into the sample cup. After the appropriate lag phase
the reaction mixture is aspirated into the thermocuvette where
equilibrium is reached, then absorbances are read over a
predetermined time and the enzyme activity calculated and
printed.
Reagent mixture
The proportions given below are sufficient for nine tests, namely
four specimens (TK and TPP effect for each) and one ’blank’.
Ribose-5-P substrate: 5 ml
Tris buffer: 5 ml
NADH solution: 250/A
GDH/TIM suspension: 50 pl.
The reagent mixture is then placed in the dispenser bottle set to
deliver 1.0ml. A proportional quantity of reagent is prepared
depending on the number of tests.
Sample loadin9
Adjacent pairs ofsample cups are used for the TK and TK-TPP
test for each patient sample, and these contain 0.5 ml buffer, and
0’45 ml buffer and 50 #1 TPP respectively.
A precision pipette is used to introduce 50/A haemolysate
into each pair of sample cups, using the ’wash-out’ technique to
transfer the haemolysate. This is then stirred with the pipette tip
to achieve even mixing of the reagent and haemolysate. Failure
to do this sometimes causes erroneous results.
A sample cup containing 0"5 ml buffer and 50 #1 haemolysate
is used as the blank and is placed in front ofthe first test sample.
This blank serves only to prime the Gilford System and its result
is not used.
Operational mode
The initial absorbance of the Gilford spectrophotometer is
adjusted to about -0"8 with water.
The ’enzyme-general mode’, test number 25, is used to
program the Gilford computer/printer. The parameters for the
TK assay are:
Wavelength: 340nm
Temperature: 37C
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Lag phase time" 1600
Equilibrium time" 300
Read time" 120
Factor’ 166.
Table 1. Analytical details of TK activities determined by
the two methods.
TK TK + TPP)
After verifying that the parameters are correct and that the
sample tray is properly positioned, the test is initiated.
Results
Comparison between two methods
Both methods showed good correlation for the TK assay
(figure 1) and for the activated TK assay (figure 2). Additional
analytical data on the two tests are given in table 1.
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Figure 1. Correlation between transketolase automated
method and the manual method.
Manual Gilford Manual Gilford
Mean (U/g Hb) 0.81 0"86 0"94 0"98
SD (U/g Hb) 0.25 0.26 0"25 0.27
Range 0.31-1.31 0.34-1.38 0.44-1.44 0.44-1.52
N 51 51 51 51
Accuracy in measurement
Accuracy was further determined by assaying two specimens
having known low (L) and high (H) TK activities and three
specimens prepared in the following proportions: (2L+ 1H),
(H+ L), (1L+ 2H). Figure 3 shows the TK activities ofthe above
samples and the expected correlation line. It would appear that
our modified method on the Gilford analyser is quite accurate.
Precision
The within-day precision determined for the modified Gilford
method on samples with ’low’ and ’high normal’ TK activities is
shown in table 2. The day-to-day precision has not been done
owing to specimen instability.
Table 2. Within-day precision determinedfor the modified
Gilford method.
Within-day precision
’Low’ TK ’High normal’ TK
Mean (U/g Hb) 0.41 1.05
SD (U/g Hb) 0.03 0.05
CV (%) 7.4 5.0
N 11 10
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Activated TK (U/g Hb). Manual method.
Figure 2. Correlation between thiamine activated trans-
ketolase automated method and the manual method.
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Stability of samples during assay
The time taken to assay five specimens (10 tests and one blank)is
about 100 min. The stability of samples over this period was
assessed on several occasions by placing them at the beginning
and at the end of the assay: no loss of enzyme activity was
detected. However, delay in excess of 2 h causes a fall in enzyme
activity of0" U/g Hb. This occurs when large batch samples are
loaded on the sample tray at the same time.
TPP ejfect
The upper limit of the TPP effect is normally taken to be 25G.
From the 51 patients randomly selected for this study, five
showed elevated (abnormal) TPP effect by the manual method
and only three were abnormal by the automated method. Ofthe
two patients who showed equivocal results, one had a normal
TK activity by both methods, but the other had a low TK and
TPP effect by the automated method. We were unable to repeat
the latter observations to confirm the finding.
Discussion
A semi-automated TK method adapted to the centrifugal fast
analyser based on the measurement ofglucose-6-phosphate has
been proposed [4]. The method of Smeets et al. has, to our
knowledge, not been automated. A disadvantage of this methodC. R. Milner et al. Measurement of erythrocyte transketolase activity on a discrete analyser
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completed. There is no loss in enzyme activity when specimens
are left in the cups for up to 100 min before analysis. Ifthis time is
markedly exceeded there is some loss in enzyme activity. Thus
for a large batch ofsay 10 specimens (i.e. 20 tests), we recommend
that the specimens be loaded in two or more stages so that they
are not left for an unduly long time. To minimize or prevent
enzyme deterioration, specimens waiting to be assayed should
be stored in a refrigerator.
For the automated assay the optimum lag time, established
mainly at room temperature which will allow the TK reaction to
proceed at a constant rate, similar to the manual method, was
found to be 1600 s, of which the last 300 s is at 37C.
The absorbance of the TK test is high and this is due to the
NADH and the haemoglobin present. Only instruments which
can offset some of this initial high absorbance will be able to
measure the decreasing NADH absorbance change due to the
TK assay. Both the Unicam SP8000 and the Gilford spectro-
photometers can do this adequately.
Extrapolated from our previous data [5], the range for the
TK activity was 0"6 to 1.3 U/glib, while the range for the
thiamine pyrophosphate (TPP) effect was 0-25?/o.
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Figure 3. Transketolase activities determined from
haemolysates prepared in varying proportions.
when performed manually is that it is very demanding on the
analyst’s time. With a suitable spectrophotometer, such as the
Unicam SP8000, four tests can be performed in an analytical
run, but despite this the change-over of tests and the calculation
of enzyme activity is time-consuming. This is not so for our
modified TK method on the Gilford analyser. Specimens can be
loaded in the sample cups and left unattended until the test is
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CONFERENCE ANNOUNCEMENT
VIIth International Symposium on Column Liquid Chromatography (2-6 May 1983)
This is the seventh in a series of successful meetings dealing with the latest developments in column liquid chromatography.
The scientific programme will comprise discussion papers and poster communications covering all aspects of the subject and
its related techniques. Lectures will be given in English.
The organizers would like to receive suggestions for papers, in the form ofa 300-word abstract, by 15 November 1982. All
submitted manscripts will be refereed by the scientific committee.
Those attending the symposium will receive a booklet containing abstracts of the discussion papers and poster
communications. Following the symposium, the papers will be published in a special edition of the Journal of
Chromatography.
The VIIth International Symposium on Column Liquid Chromatography is sponsored by the Arbeitskreis
Chromatographie der Fachgruppe Analytische Chemie in der Gesellschaft Deutscher Chemiker. Co-sponsors include the
Chromatography Forum of the Delaware Valley, Groupement Pour l’Avancement Des M6thodes Spectroscopiques
(GAMS), Koninklijke Nederlandse Chemische Vereniging, Schweizerischer Chemiker-Verband, Sociht6 Chimique de France,
Svenska Kemistsamfundet and the Verein Osterreichischer Chemiker.
An exhibition of liquid chromatography instruments and accessories will run concurrently with the meeting.
Further detailsfrom Dr J. Wendenburg, c/o Gesellschaft Deutscher Chemiker, Varrentrappstrasse 40-42, D 6000 Frankfurt 90,
FR Germany.
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